Business | Nation

High Court Sides With Regulators In Drug Patent Case

NPR | June 17, 2013 2:45 p.m. | Updated: June 17, 2013 7:26 p.m.

The Supreme Court sided with government regulators in an important case involving the pharmaceutical industry and patent law. At issue were contracts between “brand-name” pharmaceutical companies and “generic” producers in which the brand-name company paid the generic not to compete. The court said the Federal Trade Commission could challenge such contracts.

Comments

blog comments powered by Disqus
Thanks to our Sponsors:
become a sponsor
Thanks to our Sponsors
become a sponsor